Ming Fai International Holdings Limited (3828.HK)
HKD 0.78
(-1.27%)
HKD 0.78
(-1.27%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.16 Million HKD | -64.17% |
| 2022 | 6.04 Million HKD | 17.58% |
| 2021 | 5.13 Million HKD | -38.68% |
| 2020 | 8.37 Million HKD | 106.92% |
| 2019 | 4.04 Million HKD | 0.0% |
| 2018 | - HKD | 0.0% |
| 2017 | - HKD | 0.0% |
| 2016 | - HKD | -100.0% |
| 2015 | 19.43 Million HKD | -25.15% |
| 2014 | 25.97 Million HKD | -19.95% |
| 2013 | 32.44 Million HKD | -16.53% |
| 2012 | 38.86 Million HKD | -13.99% |
| 2011 | 45.19 Million HKD | -12.25% |
| 2010 | 51.49 Million HKD | -10.71% |
| 2009 | 57.67 Million HKD | 0.0% |
| 2008 | - HKD | 0.0% |
| 2007 | - HKD | 0.0% |
| 2006 | - HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Million HKD | 0.0% |
| 2024 Q1 | 1.89 Million HKD | -12.34% |
| 2023 FY | 2.16 Million HKD | -64.17% |
| 2023 Q1 | 4.02 Million HKD | -33.41% |
| 2023 Q2 | 4.02 Million HKD | 0.0% |
| 2023 Q4 | 2.16 Million HKD | -54.92% |
| 2023 Q3 | 4.8 Million HKD | 19.34% |
| 2022 Q1 | 8.57 Million HKD | 66.85% |
| 2022 Q2 | 8.57 Million HKD | 0.0% |
| 2022 Q3 | 6.04 Million HKD | -29.53% |
| 2022 FY | 6.04 Million HKD | 17.58% |
| 2022 Q4 | 6.04 Million HKD | 0.0% |
| 2021 Q2 | 6.38 Million HKD | 0.0% |
| 2021 FY | 5.13 Million HKD | -38.68% |
| 2021 Q3 | 5.13 Million HKD | -19.55% |
| 2021 Q4 | 5.13 Million HKD | 0.0% |
| 2021 Q1 | 6.38 Million HKD | -23.79% |
| 2020 FY | 8.37 Million HKD | 106.92% |
| 2020 Q4 | 8.37 Million HKD | 0.0% |
| 2020 Q3 | 8.37 Million HKD | 90.15% |
| 2020 Q1 | 4.4 Million HKD | 8.82% |
| 2020 Q2 | 4.4 Million HKD | 0.0% |
| 2019 FY | 4.04 Million HKD | 0.0% |
| 2019 Q4 | 4.04 Million HKD | 0.0% |
| 2019 Q3 | 4.04 Million HKD | -33.31% |
| 2019 Q2 | 6.07 Million HKD | 0.0% |
| 2019 Q1 | 6.07 Million HKD | 0.0% |
| 2018 Q1 | - HKD | 0.0% |
| 2018 Q3 | - HKD | 0.0% |
| 2018 Q4 | - HKD | 0.0% |
| 2018 FY | - HKD | 0.0% |
| 2018 Q2 | - HKD | 0.0% |
| 2017 Q2 | - HKD | 0.0% |
| 2017 Q3 | - HKD | 0.0% |
| 2017 FY | - HKD | 0.0% |
| 2017 Q1 | - HKD | 0.0% |
| 2017 Q4 | - HKD | 0.0% |
| 2016 Q2 | - HKD | 0.0% |
| 2016 FY | - HKD | -100.0% |
| 2016 Q4 | - HKD | 0.0% |
| 2016 Q3 | - HKD | 0.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2015 Q2 | 22.71 Million HKD | 0.0% |
| 2015 Q1 | 22.71 Million HKD | -12.54% |
| 2015 Q4 | 19.43 Million HKD | 0.0% |
| 2015 FY | 19.43 Million HKD | -25.15% |
| 2015 Q3 | 19.43 Million HKD | -14.41% |
| 2014 Q2 | 29.21 Million HKD | 0.0% |
| 2014 Q1 | 29.21 Million HKD | -9.96% |
| 2014 Q4 | 25.97 Million HKD | 0.0% |
| 2014 FY | 25.97 Million HKD | -19.95% |
| 2014 Q3 | 25.97 Million HKD | -11.1% |
| 2013 FY | 32.44 Million HKD | -16.53% |
| 2013 Q4 | 32.44 Million HKD | 0.0% |
| 2013 Q1 | 35.65 Million HKD | -8.26% |
| 2013 Q2 | 35.65 Million HKD | 0.0% |
| 2013 Q3 | 32.44 Million HKD | -9.01% |
| 2012 Q4 | 38.86 Million HKD | 0.0% |
| 2012 Q2 | 42.04 Million HKD | 0.0% |
| 2012 Q3 | 38.86 Million HKD | -7.56% |
| 2012 FY | 38.86 Million HKD | -13.99% |
| 2011 Q2 | 48.33 Million HKD | 0.0% |
| 2011 FY | 45.19 Million HKD | -12.25% |
| 2011 Q4 | 45.19 Million HKD | 0.0% |
| 2010 Q2 | 54.65 Million HKD | 0.0% |
| 2010 Q4 | 51.49 Million HKD | 0.0% |
| 2010 FY | 51.49 Million HKD | -10.71% |
| 2009 FY | 57.67 Million HKD | 0.0% |
| 2009 Q4 | 57.67 Million HKD | 0.0% |
| 2009 Q2 | - HKD | 0.0% |
| 2008 FY | - HKD | 0.0% |
| 2008 Q4 | - HKD | 0.0% |
| 2007 FY | - HKD | 0.0% |
| 2006 FY | - HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 3.49 Million HKD | 38.136% |
| Innovative Pharmaceutical Biotech Limited | 661.64 Million HKD | 99.673% |
| China Overseas Nuoxin International Holdings Limited | 9.2 Million HKD | 76.483% |
| Prosperous Future Holdings Limited | 6.33 Million HKD | 65.835% |
| Huasheng International Holding Limited | 207.84 Million HKD | 98.959% |
| Fourace Industries Group Holdings Limited | 2.39 Million HKD | 9.456% |
| Evergreen Products Group Limited | 35.17 Million HKD | 93.847% |
| EC Healthcare | 783.75 Million HKD | 99.724% |
| Blue Moon Group Holdings Limited | 101.55 Million HKD | 97.869% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | 98.437% |
| Takbo Group Holdings Limited | 7.72 Million HKD | 71.998% |
| Hyfusin Group Holdings Limited | 8.66 Million HKD | 75.037% |